HNRNPCL2
gene geneOn this page
Summary
HNRNPCL2 (heterogeneous nuclear ribonucleoprotein C like 2, HGNC:48813) is a protein-coding gene on chromosome 1p36.21, encoding Heterogeneous nuclear ribonucleoprotein C-like 2 (B2RXH8). May play a role in nucleosome assembly by neutralizing basic proteins such as A and B core hnRNPs.
Enables identical protein binding activity. Predicted to be part of ribonucleoprotein complex. Predicted to be active in nucleus.
Source: NCBI Gene 440563 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 59 total
- MANE Select transcript:
NM_001136561
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48813 |
| Approved symbol | HNRNPCL2 |
| Name | heterogeneous nuclear ribonucleoprotein C like 2 |
| Location | 1p36.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000275774 |
| Ensembl biotype | protein_coding |
| Entrez | 440563 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000621994
RefSeq mRNA: 1 — MANE Select: NM_001136561
NM_001136561
CCDS: CCDS76105
Canonical transcript exons
ENST00000619361 — 0 exons
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 81.45.
Top tissues by expression
115 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.45 | gold quality |
| bone marrow cell | CL:0002092 | 42.78 | gold quality |
| cortical plate | UBERON:0005343 | 39.83 | gold quality |
| stromal cell of endometrium | CL:0002255 | 39.74 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| bone marrow | UBERON:0002371 | 35.12 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.96 | gold quality |
| muscle tissue | UBERON:0002385 | 32.22 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| blood | UBERON:0000178 | 29.55 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.38 | gold quality |
| liver | UBERON:0002107 | 28.80 | gold quality |
| gall bladder | UBERON:0002110 | 28.74 | gold quality |
| tonsil | UBERON:0002372 | 28.67 | gold quality |
| muscle of leg | UBERON:0001383 | 28.27 | gold quality |
| urinary bladder | UBERON:0001255 | 28.26 | gold quality |
| right uterine tube | UBERON:0001302 | 28.21 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| islet of Langerhans | UBERON:0000006 | 27.74 | gold quality |
| gastrocnemius | UBERON:0001388 | 27.64 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| pancreas | UBERON:0001264 | 26.43 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| heart left ventricle | UBERON:0002084 | 25.58 | gold quality |
| myometrium | UBERON:0001296 | 25.53 | gold quality |
| calcaneal tendon | UBERON:0003701 | 25.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.19 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Hnrnpc | ENSMUSG00000060373 |
| rattus_norvegicus | LOC100911576 | ENSRNOG00000011621 |
Paralogs (6): HNRNPC (ENSG00000092199), RALY (ENSG00000125970), HNRNPCL1 (ENSG00000179172), HNRNPCL4 (ENSG00000179412), RALYL (ENSG00000184672), HNRNPCL3 (ENSG00000277058)
Protein
Protein identifiers
Heterogeneous nuclear ribonucleoprotein C-like 2 — B2RXH8 (reviewed: B2RXH8)
All UniProt accessions (1): B2RXH8
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in nucleosome assembly by neutralizing basic proteins such as A and B core hnRNPs.
Subcellular location. Nucleus.
Similarity. Belongs to the RRM HNRPC family. RALY subfamily.
RefSeq proteins (1): NP_001130033* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000504 | RRM_dom | Domain |
| IPR012677 | Nucleotide-bd_a/b_plait_sf | Homologous_superfamily |
| IPR017347 | hnRNP_C | Family |
| IPR035979 | RBD_domain_sf | Homologous_superfamily |
| IPR051186 | RRM_HNRPC/RALY_subfam | Family |
Pfam: PF00076
UniProt features (9 total): compositionally biased region 3, region of interest 2, chain 1, domain 1, coiled-coil region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-B2RXH8-F1 | 70.72 | 0.32 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 2 (showing top):
GOCC_RIBONUCLEOPROTEIN_COMPLEX, chr1p36
GO Biological Process (0):
GO Molecular Function (4): RNA binding (GO:0003723), identical protein binding (GO:0042802), nucleic acid binding (GO:0003676), protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), ribonucleoprotein complex (GO:1990904)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 2 |
| nucleic acid binding | 1 |
| protein binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1396 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HNRNPCL2 | PRAMEF18 | Q5VWM3 | 524 |
| HNRNPCL2 | PRAMEF7 | Q5VXH5 | 507 |
| HNRNPCL2 | OR52N5 | Q8NH56 | 475 |
| HNRNPCL2 | RALYL | Q86SE5 | 431 |
| HNRNPCL2 | ATP5ME | P56385 | 418 |
| HNRNPCL2 | FAM131C | Q96AQ9 | 417 |
| HNRNPCL2 | ATP5MC3 | P48201 | 399 |
| HNRNPCL2 | ATP5MC1 | P05496 | 392 |
| HNRNPCL2 | OR4K1 | Q8NGD4 | 391 |
| HNRNPCL2 | PRAMEF1 | O95521 | 370 |
| HNRNPCL2 | PRAMEF2 | O60811 | 367 |
| HNRNPCL2 | TIGD3 | Q6B0B8 | 366 |
| HNRNPCL2 | OR8U1 | Q8NH10 | 349 |
| HNRNPCL2 | SCGB1C1 | Q8TD33 | 348 |
| HNRNPCL2 | SCGB1C2 | P0DMR2 | 348 |
IntAct
58 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HNRNPCL2 | HNRNPCL1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| HNRNPCL2 | HNRNPC | psi-mi:“MI:0915”(physical association) | 0.670 |
| RALY | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIP11 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPCL2 | RALY | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPCL2 | RALYL | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPCL2 | PPP1R37 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPCL2 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HNRNPCL2 | RNF4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FLT4 | ILVBL | psi-mi:“MI:0914”(association) | 0.420 |
| SLC22A8 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HMGN5 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| AKAP9 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| PHIP | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FANCC | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FREM2 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HNRNPCL2 | PLCB2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HNRNPCL2 | RPUSD1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GLT8D2 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ANXA2 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ROCK2 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| PHACTR4 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| LRP1B | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ARHGEF11 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| C2orf78 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ERICH3 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| BROX | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| VDAC2 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MAST1 | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| FSBP | HNRNPCL2 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (290): HNRNPCL2 (Affinity Capture-MS), HNRNPCL2 (Affinity Capture-MS), HNRNPCL2 (Two-hybrid), HNRNPCL2 (Two-hybrid), HNRNPCL2 (Two-hybrid), HNRNPCL2 (Two-hybrid), HNRNPCL2 (Two-hybrid), HNRNPCL2 (Two-hybrid), HNRNPCL2 (Two-hybrid), HNRNPCL2 (Affinity Capture-MS), MRC1 (Proximity Label-MS), ECT2L (Proximity Label-MS), THUMPD2 (Proximity Label-MS), HNRNPCL2 (Proximity Label-MS), FSBP (Proximity Label-MS)
ESM2 similar proteins: B2RXH8, B7ZW38, C0SUW7, F4JP52, F4JQZ3, F4JTI1, F4KIA8, G3V9R8, O48802, O60812, O77768, P07910, P0DMR1, P19600, P93831, Q08BJ2, Q08DJ0, Q0VFL3, Q0VFL7, Q0WNR6, Q0WUR5, Q10MI4, Q149C2, Q3ED78, Q41583, Q5DU00, Q5RA82, Q5VN06, Q5XIN3, Q64012, Q6K641, Q84PB3, Q84UI6, Q86SE5, Q86XZ4, Q8BTF8, Q8K1N4, Q8RWQ4, Q8S4P4, Q8S4P6
Diamond homologs: B2RXH8, B7ZW38, G3V9R8, O60812, O77768, P07910, P0DMR1, P19600, Q08DJ0, Q0VFL7, Q5RA82, Q64012, Q86SE5, Q8BTF8, Q9UKM9, Q9V3V0, Q9Z204, Q16629, Q3T106, Q8BL97, Q9W4D2, P38996, Q13247, Q29RT0, Q3B7L6, Q9WX39, F4JHI7, O22315, P84103, P84104, Q10145, Q3SZR8, Q74ZS6, Q94901, Q9FYB7, Q9LIS2, Q9XFR5, G3V6S8, Q3TWW8, Q6IQ97
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 52 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
216 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:13116592:G:C | acceptor_gain | 0.9700 |
| 1:13116581:TC:T | acceptor_loss | 0.9600 |
| 1:13116590:A:C | acceptor_gain | 0.9600 |
| 1:13116582:C:CC | acceptor_gain | 0.9500 |
| 1:13116787:ACTT:A | donor_loss | 0.9500 |
| 1:13116788:CTT:C | donor_loss | 0.9500 |
| 1:13116577:GAATT:G | acceptor_gain | 0.9400 |
| 1:13116587:A:AC | acceptor_gain | 0.9400 |
| 1:13116590:A:AC | acceptor_gain | 0.9400 |
| 1:13116786:GACTT:G | donor_loss | 0.9400 |
| 1:13116791:A:AC | donor_gain | 0.9400 |
| 1:13116792:C:CC | donor_gain | 0.9400 |
| 1:13116592:G:GC | acceptor_gain | 0.9300 |
| 1:13116580:TT:T | acceptor_gain | 0.9200 |
| 1:13116579:ATT:A | acceptor_gain | 0.9000 |
| 1:13116579:ATTCT:A | acceptor_gain | 0.8900 |
| 1:13116580:TTCT:T | acceptor_gain | 0.8800 |
| 1:13116578:AATT:A | acceptor_gain | 0.8700 |
| 1:13116581:TCTG:T | acceptor_gain | 0.8500 |
| 1:13116582:C:A | acceptor_gain | 0.8400 |
| 1:13116583:T:A | acceptor_gain | 0.8300 |
| 1:13116578:AATTC:A | acceptor_gain | 0.8200 |
| 1:13115676:C:A | donor_gain | 0.7900 |
| 1:13116785:TGAC:T | donor_loss | 0.7700 |
| 1:13116587:A:C | acceptor_gain | 0.7300 |
| 1:13116784:GTGAC:G | donor_loss | 0.7200 |
| 1:13115766:T:TA | donor_gain | 0.6800 |
| 1:13116792:CCAG:C | donor_gain | 0.6800 |
| 1:13115710:T:A | donor_gain | 0.6500 |
| 1:13115529:T:TA | donor_gain | 0.6300 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1002232719 (1:13117918 T>G), RS1002601034 (1:13118089 T>A), RS1002618846 (1:13116940 T>A), RS1002696828 (1:13118115 G>A), RS1002748315 (1:13117669 A>G), RS1002809859 (1:13118802 C>G), RS1005741521 (1:13118085 C>G), RS1005923055 (1:13117819 A>T), RS1005934239 (1:13117625 A>C), RS1008939634 (1:13115425 A>G), RS1009143648 (1:13115139 G>A), RS1009882580 (1:13117289 C>G,T), RS1010008589 (1:13118465 C>T), RS1010065352 (1:13118123 C>A,G,T), RS1010075198 (1:13117885 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, increases mutagenesis | 2 |
| Cadmium | increases abundance, increases expression | 1 |
| Urethane | decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.